the U.S Food and Drug Administration (FDA) has cleared the QuikClot Control+ Hemostatic Device to include mild and moderate bleeding in cardiac surgical procedures and bone surface bleeding following a sternotomy
News | Cath Lab
Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
India clinical trial commences with first 30 cases
News | Heart Valve Technology
First Patients Outside of U.S. Treated with TRIA Polymer Surgical Mitral Heart Valve

August 2, 2023 — Foldax, Inc., a leader in the development of innovative, polymer heart valves, today announced that the ...

Home August 02, 2023
Home
Dr. Scortichini is recognized across the Finger Lakes and Greater Rochester region as one of the most respected and accomplished cardiologists
News | Cardiovascular Business
Dr. Doria A. Scortichini MD, FACC Joins Auburn Heart Institute

August 2, 2023 — Dr. Doria Scortichini, MD FACC joins the growing Auburn Heart Institute that is affiliated with Auburn ...

Home August 02, 2023
Home
Real-world evidence demonstrates the clinical, health equity and patient benefits of AI-powered care coordination
News | Artificial Intelligence
Three New Clinical Studies Presented at the Society of Neurointerventional Surgery Annual Meeting Further Validate Impact of Viz Neuro Suite

August 1, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced the ...

Home August 01, 2023
Home
Eleven Hackensack Meridian hospitals have been awarded the American Heart Association / American Stroke Association Get With The Guidelines Stroke Gold Plus Award.
News | Cardiovascular Business
Eleven Hackensack Meridian Health Hospitals Nationally Recognized For Stroke Care By American Heart Association and American Stroke Association Get With The Guidelines Stroke Awards

August 1, 2023 — Hackensack Meridian Health hospitals are being recognized for their readiness to respond and care for ...

Home August 01, 2023
Home
LX2020 preclinical studies demonstrated proof-of-concept with treatment restoring desmosomal integrity, reducing arrhythmias, and extending survival in a clinically relevant murine model
News | Pharmaceuticals
LEXEO Therapeutics Announces FDA Clearance of IND for LX2020, an AAV-based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy

August 1, 2023 —LEXEO Therapeutics, a clinical-stage gene therapy company advancing adeno-associated virus (AAV)-based ...

Home August 01, 2023
Home
Here is a look at what DAIC viewers were reading during the month of July
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
What Viewers Were Reading in July

Here is a look at what DAIC viewers were reading during the month of July: 1. Lessons Learned from World’s First ...

Home August 01, 2023
Home
The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)
News | Heart Valve Technology
FDA Issues Update on Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration

July 31, 2023 — Today, the U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 ...

Home July 31, 2023
Home
AI demonstrated high accuracy, reduced non-diagnostic outputs, and identified HFpEF patients with worse outcomes.
News | Cardiovascular Clinical Studies
Study Confirms Ultromics' AI Can Improve HFpEF Detection Using a Single Echocardiogram View

July 31, 2023 — Applying AI to a single apical four chamber (A4C) view echocardiogram provides accurate information to ...

Home July 31, 2023
Home
GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to the heart during defibrillation without any notification to the care provider
News | Defibrillator Monitors
GE HealthCare Recalls TruSignal SpO2 Sensors for Issues That May Reduce Defibrillation Energy, Expose Patients to Unintended Voltage, or Give Inaccurate Readings

July 28, 2023 — GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to ...

Home July 28, 2023
Home
Primary endpoints across three studies underscore the importance of accuracy, utility, and efficiency in coronary artery disease diagnostics and clinical decision making
News | Cardiovascular Clinical Studies
HeartFlow to Announce New Data at SCCT23

July 28, 2023 — Respective results from the REVEALPLAQUE, DECODE, and SMART-CT clinical studies demonstrate the accuracy ...

Home July 28, 2023
Home
New calculator is based on precise statistical models from more than 8 million patients
News | Heart Failure
The Society of Thoracic Surgeons Launches Next-generation Adult Cardiac Surgery Risk Calculator

July 28, 2023 — The Society of Thoracic Surgeons has launched its next-generation Operative Risk Calculator to assess ...

Home July 28, 2023
Home
Device manufacturers will be displaying their latest technologies at the 2023 Society of Cardiovascular Computed Tomography Annual Scientific Meeting (SCCT2023) being held in Boston from July 27 - 30.
Feature | SCCT
Innovations in Photon Counting CT, AI to be Showcased at SCCT2023

Device manufacturers will be displaying their latest technologies at the 2023 Society of Cardiovascular Computed ...

Home July 28, 2023
Home
New AI guidance software will allow more medical professionals to conduct cardiac ultrasound in multiple care settings expanding patient access to cardiac imaging
News | Cardiovascular Ultrasound
FDA Grants Clearance for UltraSight’s AI-Powered Cardiac Ultrasound Technology

July 27, 2023 —UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial ...

Home July 27, 2023
Home
Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions for Use (IFU) do not adequately address precautions to take when treating patients who have undergone transcatheter aortic valve replacement (TAVR)
News | Stents
Abiomed Recalls All Impella Left Sided Blood Pumps for Risk of Motor Damage After Contact with Transcatheter Aortic Valve Replacement (TAVR) Stent

July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...

Home July 27, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now